(OZEM) Roundhill GLP-1 & Weight - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Health
OZEM: GLP-1, Weight Loss, Pharmaceuticals, Biotechnology, Healthcare
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
Additional Sources for OZEM ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
OZEM ETF Overview
| Market Cap in USD | 41m |
| Category | Health |
| TER | 0.59% |
| IPO / Inception | 2024-05-20 |
OZEM ETF Ratings
| Growth 5y | -33.2% |
| Fundamental | - |
| Dividend | 7.34% |
| Rel. Strength Industry | -133 |
| Analysts | - |
| Fair Price Momentum | 21.43 USD |
| Fair Price DCF | - |
OZEM Dividends
| Dividend Yield 12m | 0.22% |
| Yield on Cost 5y | 0.21% |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 100.0% |
OZEM Growth Ratios
| Growth Correlation 3m | -89.9% |
| Growth Correlation 12m | -16.6% |
| Growth Correlation 5y | -16.6% |
| CAGR 5y | -5.69% |
| CAGR/Mean DD 5y | -1.07 |
| Sharpe Ratio 12m | -0.46 |
| Alpha | -33.34 |
| Beta | 1.04 |
| Volatility | 25.51% |
| Current Volume | 11.4k |
| Average Volume 20d | 23.8k |
What is the price of OZEM stocks?
As of January 23, 2025, the stock is trading at USD 23.88 with a total of 11,353 shares traded.
Over the past week, the price has changed by +0.87%, over one month by -3.87%, over three months by -15.43% and over the past year by -5.69%.
As of January 23, 2025, the stock is trading at USD 23.88 with a total of 11,353 shares traded.
Over the past week, the price has changed by +0.87%, over one month by -3.87%, over three months by -15.43% and over the past year by -5.69%.
Is Roundhill GLP-1 & Weight a good stock to buy?
Probably not. Based on ValueRay Analyses, Roundhill GLP-1 & Weight (NASDAQ:OZEM) is currently (January 2025) not a good stock to buy. It has a ValueRay Growth Rating of -33.18 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OZEM as of January 2025 is 21.43. This means that OZEM is currently overvalued and has a potential downside of -10.26%.
Probably not. Based on ValueRay Analyses, Roundhill GLP-1 & Weight (NASDAQ:OZEM) is currently (January 2025) not a good stock to buy. It has a ValueRay Growth Rating of -33.18 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OZEM as of January 2025 is 21.43. This means that OZEM is currently overvalued and has a potential downside of -10.26%.
Is OZEM a buy, sell or hold?
Roundhill GLP-1 & Weight has no consensus analysts rating.
Roundhill GLP-1 & Weight has no consensus analysts rating.
What are the forecast for OZEM stock price target?
According to ValueRays Forecast Model, OZEM Roundhill GLP-1 & Weight will be worth about 23.9 in January 2026. The stock is currently trading at 23.88. This means that the stock has a potential downside of -0.08%.
According to ValueRays Forecast Model, OZEM Roundhill GLP-1 & Weight will be worth about 23.9 in January 2026. The stock is currently trading at 23.88. This means that the stock has a potential downside of -0.08%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 23.9 | -0.1% |